We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.

placeholder="Enter search term...">
Suitcase

Dengue Fever in Fiji

27 February 2017

A media reportof 26 February 2017, quoting Ministry of Health sources, is advising that there have been 143 cases of dengue fever recorded in the first six weeks of 2017. Western Division recorded the highest number of cases (88), followed by Northern Division (30) and Central/Eastern Division (25).

Advice for Travellers

All travellers to endemic regions are potentially at risk of dengue fever and should be aware of this infection. Prevention relies on avoiding mosquito bites.

Vaccine

There is no vaccine against dengue fever licensed in the UK.

Dengvaxia®, developed by Sanofi Pasteur MSD, is the first vaccine to be licensed in the world for the prevention of dengue.

    • Mexico, Costa Rica, the Phillipines and Brazil are the first countries to have granted marketing authorization for Dengvaxia®

At present the World Health Organisation (WHO) is trialling several candidate vaccines against dengue fever.